Ingelheim India is thrilled to establish a strategic distribution partnership with Vvaan Lifesciences Private Limited for their pet parasiticide range.
Boehringer Ingelheim India’s Animal Health Accelerated Growth Plan (AGP) includes this collaboration, which expands their reach and improves animal health customer value.
Pet health is a €115 million industry in India. Internal estimates from Boehringer Ingelheim India indicate that over 60% of total revenues come from metros and Tier 1 cities, with Tier 2 and smaller cities making up the remaining portion.
This alliance uses Vvaan Lifesciences’ considerable experience in the animal health industry to expand Boehringer Ingelheim India’s pet offering into Tier 2 cities as part of its ongoing goal to promote animal health.
Through this partnership, the company hopes to increase its clientele in underserved areas, fulfill the increasing need in mini metros, and raise the bar for veterinary treatment throughout India.
Read also- Georgia-Based Equifax Strategic Partnership with Workday
Dr. Vinod Gopal, Country Head-Animal Health, Boehringer Ingelheim India, said, “At Boehringer Ingelheim, we are deeply committed to making our innovative, high-quality medications accessible to all, regardless of geographical location. We understand the unique challenges faced by non-metro and rural communities in accessing quality healthcare for pet parents and their pets. Our strategic partnership with Vvaan Lifesciences is a significant step towards bridging this gap. This collaboration will enable us to reach and serve these underserved markets effectively, significantly enhancing the health and well-being of pets in non-metro and rural areas.”
Boehringer Ingelheim’s focus to innovation and quality in animal health is emphasized by this agreement, which furthers their commitment to enhancing the quality of life for pets throughout India.
Read also- Quebit Capital’s AI-driven startup-investor matchmaking disrupts global funding
Speaking on the partnership, Dr. Maneesh Jain, Director & CEO, Vvaan Lifesciences Private Limited, said, “We are excited about this partnership with Boehringer Ingelheim. Our strong presence in Tier 2 cities, combined with Boehringer Ingelheim’s innovative pet parasiticide products, will significantly improve the availability and quality of pet healthcare across India. We look forward to working together to make a positive impact on the lives of pets and pet parents in these regions, with the support of vets.”
About Boehringer Ingelheim India
Boehringer Ingelheim is a multinational conglomerate that embraces a wide range of countries and cultures. Find out more about the company’s history, organization, board of managing directors, financial highlights, and commitment to environmental, cultural, and scientific endeavors.
About Vvaan Lifesciences Pvt Ltd
Vvaan Lifesciences Pvt Ltd. improves animal health, production, and performance. The staff has decades of dairy, poultry, and companion animal experience.
